Identification of <i>MiR-93-5p</i> Targeted Pathogenic Markers in Acute Myeloid Leukemia through Integrative Bioinformatics Analysis and Clinical Validation

<div>The different expression of <i>VEGF</i> between AML and healthy group. Ctrl represents the healthy group.</div>

Journal of Oncology

fig16

Figure 16

Figure 16: Identification of <i>MiR-93-5p</i> Targeted Pathogenic Markers in Acute Myeloid Leukemia through Integrative Bioinformatics Analysis and Clinical Validation 

Figure 16 | Identification of MiR-93-5p Targeted Pathogenic Markers in Acute Myeloid Leukemia through Integrative Bioinformatics Analysis and Clinical Validation 